Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults

被引：0
|
作者：
Nils von Hentig
Brenda Dauer
Annette Haberl
Stefan Klauke
Thomas Lutz
Schlomo Staszewski
Sebastian Harder
机构：
[1] Johann Wolfgang Goethe University,Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology
[2] JohannWolfgang Goethe University Hospital Frankfurt,Medical HIV
[3] Infektiologicum Frankfurt,Treatment and Research Unit
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
HAART; Drug-drug interaction; TDM; Atazanavir; Tenofovir-DF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [32] Effect of Nevirapine on the Steady-State Trough Concentrations of Atazanavir in HIV-Infected Patients Receiving Atazanavir/Ritonavir
    Molto, Jose
    Deig, Elisabet
    Valle, Marta
    Maria Llibre, Josep
    Miranda, Cristina
    Cedeno, Samandhy
    Valero, Silvia
    Negredo, Eugenia
    Clotet, Bonaventura
    THERAPEUTIC DRUG MONITORING, 2010, 32 (01) : 93 - 96
  • [33] Ritonavir-boosted atazanavir may be efficacious in HIV-infected patients concurrently receiving omeprazole
    Chan-Tack, KM
    Edozien, A
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (09) : 1344 - 1344
  • [34] Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers
    Burger, D. M.
    Agarwala, S.
    Child, M.
    Been-Tiktak, A.
    Wang, Y.
    Bertz, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3336 - 3342
  • [35] Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir
    Guiard-Schmid, JB
    Poirier, JM
    Bonnard, P
    Meynard, JL
    Slama, L
    Lukiana, T
    Jaillon, P
    Pialoux, G
    AIDS, 2005, 19 (16) : 1937 - 1938
  • [36] Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir
    Meynard, JL
    Poirier, JM
    Bonnard, P
    Meynard, JL
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 393 - 394
  • [37] Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient
    Cattaneo, Dario
    Meraviglia, Paola
    Cozzi, Valeria
    Baldelli, Sara
    Milani, Greta
    Clementi, Emilio
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (02) : 204 - 206
  • [38] Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients
    Seminari, E
    Guffanti, M
    Villani, P
    Gianotti, N
    Cusato, M
    Fusetti, G
    Galli, A
    Castagna, A
    Regazzi, M
    Lazzarin, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 545 - 549
  • [39] Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients
    Elena Seminari
    Monica Guffanti
    Paola Villani
    Nicola Gianotti
    Maria Cusato
    Giuliana Fusetti
    Andrea Galli
    Antonella Castagna
    Mario Regazzi
    Adriano Lazzarin
    European Journal of Clinical Pharmacology, 2005, 61 : 545 - 549
  • [40] The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients
    Kruse, G
    Esser, S
    Stocker, H
    Breske, A
    Koerber, A
    Kopperman, M
    Wiehler, H
    Ross, B
    Möcklinghoff, C
    Hill, A
    Becker, M
    Kurowski, M
    ANTIVIRAL THERAPY, 2005, 10 (02) : 349 - 355
12345